Medicamen Organics Ltd.
•₹ 24.30%
2026-08-21
PROS
- Operating margins have improved to 15.0% from 6.7%
- Company comfortably covers its interest (9.1x coverage)
- Company maintains a comfortable, low leverage position
CONS
- Operating cash flow has been negative in recent years
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -1.33x)
- Equity base is being diluted - shares outstanding up 95.0%
- Working capital days have increased from 82 to 170 days
- Free cash flow has been persistently negative
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | MEDIORG | 24.30 | 0.00 | 29.56 | 0.00 | — | — | — | — | 16.97 | — |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 25 | 21 | 22 | 25 | 37 | |
| 23 | 20 | 20 | 21 | 32 | |
| Operating Profit | 2 | 1 | 3 | 6 | 6 |
| OPM % | 7 | 7 | 12 | 23 | 15 |
| Other Income | 0 | 0 | 1 | 1 | 0 |
| Interest | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 |
| 0 | 0 | 1 | 4 | 4 | |
| Tax % | 39 | 60 | 29 | 41 | 25 |
| Net Profit | 0 | 0 | 1 | 3 | 3 |
| EPS | 0 | 0 | 2 | 3 | 3 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 0 | 2 | 3 | 3 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 0 | 2 | 3 | 3 |
Mar 2021
- 25
- 23
- Operating Profit
- 2
- OPM %
- 7
- Other Income
- 0
- Interest
- 0
- Depreciation
- 1
- 0
- Tax %
- 39
- Net Profit
- 0
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2022
- 21
- 20
- Operating Profit
- 1
- OPM %
- 7
- Other Income
- 0
- Interest
- 0
- Depreciation
- 1
- 0
- Tax %
- 60
- Net Profit
- 0
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2023
- 22
- 20
- Operating Profit
- 3
- OPM %
- 12
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 1
- Tax %
- 29
- Net Profit
- 1
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2024
- 25
- 21
- Operating Profit
- 6
- OPM %
- 23
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 4
- Tax %
- 41
- Net Profit
- 3
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2025
- 37
- 32
- Operating Profit
- 6
- OPM %
- 15
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 4
- Tax %
- 25
- Net Profit
- 3
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 21%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 218%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 12%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 11%
- 3 Years:
- 16%
- Last Year:
- 15%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - |
| Equity Capital | 6 | 6 | 6 | 9 | 12 |
| 1 | 2 | 3 | 7 | 17 | |
| 8 | 9 | 11 | 12 | 12 | |
| Trade Payables | 7 | 7 | 9 | 7 | 12 |
| 3 | 3 | 3 | 4 | 5 | |
| Total Liabilities | 26 | 28 | 33 | 38 | 57 |
| ASSETS | - | - | - | - | - |
| 11 | 11 | 11 | 10 | 10 | |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 2 |
| 3 | 5 | 6 | 6 | 7 | |
| 0 | 0 | 0 | 17 | 25 | |
| Cash & Bank | 1 | 0 | 1 | 1 | 3 |
| 11 | 11 | 15 | 5 | 9 | |
| Total Assets | 26 | 28 | 33 | 38 | 57 |
| Total Debt | 10 | 10 | 12 | 13 | 12 |
| Net Working Capital | -2 | -2 | -1 | 6 | 17 |
| Contingent Liabilities | 0 | 0 | 0 | 2 | 2 |
| Book Value per Share | 12.45 | 13.35 | 14.97 | 17.74 | 24.76 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 10 | 10 | 12 | 13 | 12 |
| Net Working Capital | -2 | -2 | -1 | 6 | 17 |
| Contingent Liabilities | 0 | 0 | 0 | 2 | 2 |
| Book Value per Share | 12.45 | 13.35 | 14.97 | 17.74 | 24.76 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2021
- Equity Capital
- 6
- 1
- 8
- Trade Payables
- 7
- 3
- Total Liabilities
- 26
- 11
- Capital Work in Progress
- 0
- 3
- 0
- Cash & Bank
- 1
- 11
- Total Assets
- 26
- Total Debt
- 10
- Net Working Capital
- -2
- Contingent Liabilities
- 0
- Book Value per Share
- 12.45
- Face Value
- 10.00
- Total Debt
- 10
- Net Working Capital
- -2
- Contingent Liabilities
- 0
- Book Value per Share
- 12.45
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 6
- 2
- 9
- Trade Payables
- 7
- 3
- Total Liabilities
- 28
- 11
- Capital Work in Progress
- 0
- 5
- 0
- Cash & Bank
- 0
- 11
- Total Assets
- 28
- Total Debt
- 10
- Net Working Capital
- -2
- Contingent Liabilities
- 0
- Book Value per Share
- 13.35
- Face Value
- 10.00
- Total Debt
- 10
- Net Working Capital
- -2
- Contingent Liabilities
- 0
- Book Value per Share
- 13.35
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 6
- 3
- 11
- Trade Payables
- 9
- 3
- Total Liabilities
- 33
- 11
- Capital Work in Progress
- 0
- 6
- 0
- Cash & Bank
- 1
- 15
- Total Assets
- 33
- Total Debt
- 12
- Net Working Capital
- -1
- Contingent Liabilities
- 0
- Book Value per Share
- 14.97
- Face Value
- 10.00
- Total Debt
- 12
- Net Working Capital
- -1
- Contingent Liabilities
- 0
- Book Value per Share
- 14.97
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 9
- 7
- 12
- Trade Payables
- 7
- 4
- Total Liabilities
- 38
- 10
- Capital Work in Progress
- 0
- 6
- 17
- Cash & Bank
- 1
- 5
- Total Assets
- 38
- Total Debt
- 13
- Net Working Capital
- 6
- Contingent Liabilities
- 2
- Book Value per Share
- 17.74
- Face Value
- 10.00
- Total Debt
- 13
- Net Working Capital
- 6
- Contingent Liabilities
- 2
- Book Value per Share
- 17.74
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 12
- 17
- 12
- Trade Payables
- 12
- 5
- Total Liabilities
- 57
- 10
- Capital Work in Progress
- 2
- 7
- 25
- Cash & Bank
- 3
- 9
- Total Assets
- 57
- Total Debt
- 12
- Net Working Capital
- 17
- Contingent Liabilities
- 2
- Book Value per Share
- 24.76
- Face Value
- 10.00
- Total Debt
- 12
- Net Working Capital
- 17
- Contingent Liabilities
- 2
- Book Value per Share
- 24.76
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| -1 | 0 | -1 | -4 | -5 | |
| Cash from Investing | -0 | -1 | -0 | -0 | -3 |
| Cash from Financing | 1 | 0 | 1 | 4 | 10 |
| 0 | -0 | 0 | 0 | 3 | |
| Free Cash Flow | -1 | -1 | -1 | -5 | -7 |
| OCF / Net Profit | -3.91 | 0.37 | -0.60 | -1.40 | -1.50 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
| OCF / Net Profit | -3.91 | 0.37 | -0.60 | -1.40 | -1.50 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
Mar 2021
- -1
- Cash from Investing
- -0
- Cash from Financing
- 1
- 0
- Free Cash Flow
- -1
- OCF / Net Profit
- -3.91
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -3.91
- Cumulative 5-Year FCF
- 0
Mar 2022
- 0
- Cash from Investing
- -1
- Cash from Financing
- 0
- -0
- Free Cash Flow
- -1
- OCF / Net Profit
- 0.37
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.37
- Cumulative 5-Year FCF
- 0
Mar 2023
- -1
- Cash from Investing
- -0
- Cash from Financing
- 1
- 0
- Free Cash Flow
- -1
- OCF / Net Profit
- -0.60
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.60
- Cumulative 5-Year FCF
- 0
Mar 2024
- -4
- Cash from Investing
- -0
- Cash from Financing
- 4
- 0
- Free Cash Flow
- -5
- OCF / Net Profit
- -1.40
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.40
- Cumulative 5-Year FCF
- 0
Mar 2025
- -5
- Cash from Investing
- -3
- Cash from Financing
- 10
- 3
- Free Cash Flow
- -7
- OCF / Net Profit
- -1.50
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.50
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - |
| EPS (₹) | 0.50 | 0.17 | 1.62 | 3.05 | 2.80 |
| Book Value (₹) | 12.45 | 13.35 | 14.97 | 17.74 | 24.76 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 1.63 | 1.30 | 2.80 | 3.89 | 3.43 |
| PROFITABILITY | - | - | - | - | - |
| Operating Margin % | 6.57% | 6.72% | 12.12% | 18.75% | 15.02% |
| Net Margin % | 1.19% | 0.48% | 4.38% | 10.38% | 8.82% |
| ROE % | 3.99% | 1.31% | 11.41% | 21.65% | 14.79% |
| ROCE % | 5.67% | 4.13% | 10.11% | 20.88% | 14.13% |
| 1.13% | 0.38% | 3.22% | 7.39% | 6.82% | |
| EFFICIENCY | - | - | - | - | - |
| Debtor Days | 110 | 120 | 140 | 198 | 204 |
| Inventory Days | 39 | 64 | 89 | 89 | 67 |
| Payable Days | 203 | 463 | 299 | 320 | 286 |
| -55 | -279 | -69 | -33 | -15 | |
| FINANCIAL HEALTH | - | - | - | - | - |
| Debt to Equity (x) | 1.28x | 1.28x | 1.31x | 0.83x | 0.42x |
| Interest Coverage (x) | 2.03x | 1.54x | 3.22x | 7.85x | 9.09x |
| 0.86x | 0.88x | 0.95x | 1.26x | 1.66x | |
| GROWTH | - | - | - | - | - |
| Revenue Growth % | 0.00% | -16.26% | 5.59% | 14.11% | 46.76% |
| Operating Profit Growth % | 0.00% | -14.40% | 90.54% | 116.26% | -2.37% |
| Net Profit Growth % | 0.00% | -65.98% | 855.92% | 170.74% | 24.64% |
| 0.00% | 0.00% | 0.00% | 88.89% | -8.39% | |
| VALUATION | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 7.76x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.88x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 3.57x | 6.04x |
Mar 2021
- EPS (₹)
- 0.50
- Book Value (₹)
- 12.45
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.63
- Operating Margin %
- 6.57%
- Net Margin %
- 1.19%
- ROE %
- 3.99%
- ROCE %
- 5.67%
- 1.13%
- Debtor Days
- 110
- Inventory Days
- 39
- Payable Days
- 203
- -55
- Debt to Equity (x)
- 1.28x
- Interest Coverage (x)
- 2.03x
- 0.86x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 0.17
- Book Value (₹)
- 13.35
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.30
- Operating Margin %
- 6.72%
- Net Margin %
- 0.48%
- ROE %
- 1.31%
- ROCE %
- 4.13%
- 0.38%
- Debtor Days
- 120
- Inventory Days
- 64
- Payable Days
- 463
- -279
- Debt to Equity (x)
- 1.28x
- Interest Coverage (x)
- 1.54x
- 0.88x
- Revenue Growth %
- -16.26%
- Operating Profit Growth %
- -14.40%
- Net Profit Growth %
- -65.98%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 1.62
- Book Value (₹)
- 14.97
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.80
- Operating Margin %
- 12.12%
- Net Margin %
- 4.38%
- ROE %
- 11.41%
- ROCE %
- 10.11%
- 3.22%
- Debtor Days
- 140
- Inventory Days
- 89
- Payable Days
- 299
- -69
- Debt to Equity (x)
- 1.31x
- Interest Coverage (x)
- 3.22x
- 0.95x
- Revenue Growth %
- 5.59%
- Operating Profit Growth %
- 90.54%
- Net Profit Growth %
- 855.92%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 3.05
- Book Value (₹)
- 17.74
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.89
- Operating Margin %
- 18.75%
- Net Margin %
- 10.38%
- ROE %
- 21.65%
- ROCE %
- 20.88%
- 7.39%
- Debtor Days
- 198
- Inventory Days
- 89
- Payable Days
- 320
- -33
- Debt to Equity (x)
- 0.83x
- Interest Coverage (x)
- 7.85x
- 1.26x
- Revenue Growth %
- 14.11%
- Operating Profit Growth %
- 116.26%
- Net Profit Growth %
- 170.74%
- 88.89%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 3.57x
Mar 2025
- EPS (₹)
- 2.80
- Book Value (₹)
- 24.76
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.43
- Operating Margin %
- 15.02%
- Net Margin %
- 8.82%
- ROE %
- 14.79%
- ROCE %
- 14.13%
- 6.82%
- Debtor Days
- 204
- Inventory Days
- 67
- Payable Days
- 286
- -15
- Debt to Equity (x)
- 0.42x
- Interest Coverage (x)
- 9.09x
- 1.66x
- Revenue Growth %
- 46.76%
- Operating Profit Growth %
- -2.37%
- Net Profit Growth %
- 24.64%
- -8.39%
- P/E (x)
- 7.76x
- P/B (x)
- 0.88x
- Dividend Yield %
- 0.00%
- 6.04x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Jun 2025
Nov 2024
Oct 2024